Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Zuber

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Nature Protocols|February 3, 2019
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFluteBinbin Wang, Mei Wang, Wubing Zhang, et al.
Cancer Cell|May 6, 2014
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemiaChong Chen, Yu Liu, Amy R Rappaport, et al.
Science (New York, N.Y.)|September 8, 2022
Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteinsCatarina Pechincha, Sven Groessl, Robert Kalis, et al.
Clinical and Translational Medicine|December 26, 2025
Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancerCristina Queralt, Cristina Moreta-Moraleda, Marta Costa, et al.
Cancers|August 7, 2021
Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance DevelopmentTabea L Bauer, Katrin Collmar, Till Kaltofen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemiaDorothea Rudolph, Maria Antonietta Impagnatiello, Claudia Blaukopf, et al.
Blood|July 19, 2018
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosisNiklas Mueller, Daniel Wicklein, Gregor Eisenwort, et al.
Elife|August 8, 2023
Precision RNAi using synthetic shRNAmir target sitesThomas Hoffmann, Alexandra Hörmann, Maja Corcokovic, et al.
Cell Reports|September 23, 2020
SFPQ Depletion Is Synthetically Lethal with BRAF<sup>V600E</sup> in Colorectal Cancer CellsKathleen Klotz-Noack, Bertram Klinger, Maria Rivera, et al.
Elife|July 11, 2017
Synthetic lethality between the cohesin subunits <i>STAG1</i> and <i>STAG2</i> in diverse cancer contextsPetra van der Lelij, Simone Lieb, Julian Jude, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Nature Protocols|February 3, 2019
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFluteBinbin Wang, Mei Wang, Wubing Zhang, et al.
Cancer Cell|May 6, 2014
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemiaChong Chen, Yu Liu, Amy R Rappaport, et al.
Science (New York, N.Y.)|September 8, 2022
Lysosomal enzyme trafficking factor LYSET enables nutritional usage of extracellular proteinsCatarina Pechincha, Sven Groessl, Robert Kalis, et al.
Clinical and Translational Medicine|December 26, 2025
Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancerCristina Queralt, Cristina Moreta-Moraleda, Marta Costa, et al.
Cancers|August 7, 2021
Functional Analysis of Non-Genetic Resistance to Platinum in Epithelial Ovarian Cancer Reveals a Role for the MBD3-NuRD Complex in Resistance DevelopmentTabea L Bauer, Katrin Collmar, Till Kaltofen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 11, 2015
Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemiaDorothea Rudolph, Maria Antonietta Impagnatiello, Claudia Blaukopf, et al.
Blood|July 19, 2018
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosisNiklas Mueller, Daniel Wicklein, Gregor Eisenwort, et al.
Elife|August 8, 2023
Precision RNAi using synthetic shRNAmir target sitesThomas Hoffmann, Alexandra Hörmann, Maja Corcokovic, et al.
Cell Reports|September 23, 2020
SFPQ Depletion Is Synthetically Lethal with BRAF<sup>V600E</sup> in Colorectal Cancer CellsKathleen Klotz-Noack, Bertram Klinger, Maria Rivera, et al.
Elife|July 11, 2017
Synthetic lethality between the cohesin subunits <i>STAG1</i> and <i>STAG2</i> in diverse cancer contextsPetra van der Lelij, Simone Lieb, Julian Jude, et al.
Pageof 17